﻿<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.0//EN" "http://www.ncbi.nlm.nih.gov:80/entrez/query/static/PubMed.dtd"[]>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Science and Education Publishing</PublisherName>
      <JournalTitle>American Journal of Medical Case Reports</JournalTitle>
      <Issn>2374-216X</Issn>
      <Volume>4</Volume>
      <Issue>5</Issue>
      <PubDate PubStatus="epublish">
        <Year>2016</Year>
        <Month>5</Month>
        <Day>30</Day>
      </PubDate>
    </Journal>
    <ArticleTitle>Case Report: A 12-Year History of Autoimmune Disease Systemic Lupus Erythematosus</ArticleTitle>
    <FirstPage>175</FirstPage>
    <LastPage>179</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Eva</FirstName>
        <LastName>Kovacs-Benke</LastName>
        <Affiliation>Cancer Immunology Research, 4127 Birsfelden, Switzerland</Affiliation>
      </Author>
    </AuthorList>
    <ArticleIdList>
      <ArticleId IdType="pii">AJMCR2016459</ArticleId>
      <ArticleId IdType="doi">10.12691/ajmcr-4-5-9</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2016</Year>
        <Month>1</Month>
        <Day>23</Day>
      </PubDate>
      <PubDate PubStatus="revised">
        <Year>2016</Year>
        <Month>3</Month>
        <Day>17</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2016</Year>
        <Month>5</Month>
        <Day>28</Day>
      </PubDate>
    </History>
    <Abstract>Systemic lupus erythematosus (SLE) is a chronic, autoimmune, connective tissue disorder with multi-organ involvement. Reported here is the case of a 33-year-young women with a 12-year history of lupus erythematosus. The article documents the development of lupus: First phase/ preliminary phase (13-21 years of life); Second phase/acute cutaneous lupus erythematosus (22-27 years of life); Third phase/systemic lupus erythematosus (from 28 years of life). The parameters of serological test and blood test were measured regularly during the course of the disease. The MRI-investigation was carried out three times. The clinical symptoms are evaluated in relation to the laboratory parameters All these data with the therapeutic modalities and the trigger factor(s) are disclosed.</Abstract>
  </Article>
</ArticleSet>